• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

INPP5F 易位至细胞质并与 ASPH 相互作用,促进肝癌肿瘤生长。

INPP5F translocates into cytoplasm and interacts with ASPH to promote tumor growth in hepatocellular carcinoma.

机构信息

Department of Hepatobiliary Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, China.

Guangdong Province Key laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, China.

出版信息

J Exp Clin Cancer Res. 2022 Jan 7;41(1):13. doi: 10.1186/s13046-021-02216-x.

DOI:10.1186/s13046-021-02216-x
PMID:34996491
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8740451/
Abstract

BACKGROUND

Increasing evidence has suggested inositol polyphosphate 5-phosphatase family contributes to tumorigenesis and tumor progression. However, the role of INPP5F in hepatocellular carcinoma (HCC) and its underlying mechanisms is unclear.

METHODS

The expression of INPP5F in HCC was analyzed in public databases and our clinical specimens. The biological functions of INPP5F were investigated in vitro and vivo. The molecular mechanism of INPP5F in regulating tumor growth were studied by transcriptome-sequencing analysis, mass spectrometry analysis, immunoprecipitation assay and immunofluorescence assay.

RESULTS

High expression of INPP5F was found in HCC tissues and was associated with poor prognosis in HCC patients. Overexpression of INPP5F promoted HCC cell proliferation, and vice versa. Knockdown of INPP5F suppressed tumor growth in vivo. Results from transcriptome-sequencing analysis showed INPP5F not only regulated a series of cell cycle related genes expression (c-MYC and cyclin E1), but also promoted many aerobic glycolysis related genes expression. Further studies confirmed that INPP5F could enhance lactate production and glucose consumption in HCC cell. Mechanistically, INPP5F activated Notch signaling pathway and upregulated c-MYC and cyclin E1 in HCC via interacting with ASPH. Interestingly, INPP5F was commonly nuclear-located in cells of adjacent non-tumor tissues, while in HCC, cytoplasm-located was more common. LMB (nuclear export inhibitor) treatment restricted INPP5F in nucleus and was associated with inhibition of Notch signaling and cell proliferation. Sequence of nuclear localization signals (NLSs) and nuclear export signals (NESs) in INPP5F aminoacidic sequence were then identified. Alteration of the NLSs or NESs influenced the localization of INPP5F and the expression of its downstream molecules. Furthermore, we found INPP5F interacted with both exportin and importin through NESs and NLSs, respectively, but the interaction with exportin was stronger, leading to cytoplasmic localization of INPP5F in HCC.

CONCLUSION

These findings indicate that INPP5F functions as an oncogene in HCC via a translocation mechanism and activating ASPH-mediated Notch signaling pathway. INPP5F may serve as a potential therapeutic target for HCC patients.

摘要

背景

越来越多的证据表明肌醇多磷酸 5-磷酸酶家族有助于肿瘤发生和肿瘤进展。然而,INPP5F 在肝细胞癌 (HCC) 中的作用及其潜在机制尚不清楚。

方法

在公共数据库和我们的临床标本中分析 INPP5F 在 HCC 中的表达。在体外和体内研究 INPP5F 的生物学功能。通过转录组测序分析、质谱分析、免疫沉淀测定和免疫荧光测定研究 INPP5F 调节肿瘤生长的分子机制。

结果

在 HCC 组织中发现 INPP5F 高表达,与 HCC 患者的预后不良相关。INPP5F 的过表达促进 HCC 细胞增殖,反之亦然。INPP5F 的敲低抑制体内肿瘤生长。转录组测序分析结果表明,INPP5F 不仅调节一系列细胞周期相关基因的表达(c-MYC 和细胞周期蛋白 E1),还促进许多有氧糖酵解相关基因的表达。进一步的研究证实,INPP5F 可以增强 HCC 细胞中的乳酸生成和葡萄糖消耗。在机制上,INPP5F 通过与 ASPH 相互作用激活 Notch 信号通路并上调 HCC 中的 c-MYC 和细胞周期蛋白 E1。有趣的是,在相邻非肿瘤组织的细胞中,INPP5F 通常位于核内,而在 HCC 中,位于细胞质内更为常见。LMB(核输出抑制剂)处理将 INPP5F 限制在核内,与 Notch 信号和细胞增殖的抑制有关。然后鉴定了 INPP5F 氨基酸序列中的核定位信号 (NLS) 和核输出信号 (NES)。NLS 或 NES 的改变影响 INPP5F 的定位及其下游分子的表达。此外,我们发现 INPP5F 通过 NES 和 NLS 分别与输出蛋白和导入蛋白相互作用,但与输出蛋白的相互作用更强,导致 INPP5F 在 HCC 中发生细胞质定位。

结论

这些发现表明,INPP5F 通过易位机制发挥 HCC 中的癌基因作用,并激活 ASPH 介导的 Notch 信号通路。INPP5F 可能成为 HCC 患者的潜在治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/feac/8740451/716e1832e6d2/13046_2021_2216_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/feac/8740451/b976620b2884/13046_2021_2216_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/feac/8740451/55fe4e1da023/13046_2021_2216_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/feac/8740451/b383ffec6b44/13046_2021_2216_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/feac/8740451/4b0218d95a5b/13046_2021_2216_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/feac/8740451/61f46b1ab610/13046_2021_2216_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/feac/8740451/1f09687af06a/13046_2021_2216_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/feac/8740451/c9b466457f41/13046_2021_2216_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/feac/8740451/716e1832e6d2/13046_2021_2216_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/feac/8740451/b976620b2884/13046_2021_2216_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/feac/8740451/55fe4e1da023/13046_2021_2216_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/feac/8740451/b383ffec6b44/13046_2021_2216_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/feac/8740451/4b0218d95a5b/13046_2021_2216_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/feac/8740451/61f46b1ab610/13046_2021_2216_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/feac/8740451/1f09687af06a/13046_2021_2216_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/feac/8740451/c9b466457f41/13046_2021_2216_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/feac/8740451/716e1832e6d2/13046_2021_2216_Fig8_HTML.jpg

相似文献

1
INPP5F translocates into cytoplasm and interacts with ASPH to promote tumor growth in hepatocellular carcinoma.INPP5F 易位至细胞质并与 ASPH 相互作用,促进肝癌肿瘤生长。
J Exp Clin Cancer Res. 2022 Jan 7;41(1):13. doi: 10.1186/s13046-021-02216-x.
2
Aspartate β-hydroxylase modulates cellular senescence through glycogen synthase kinase 3β in hepatocellular carcinoma.天冬氨酸β-羟化酶通过糖原合酶激酶3β调节肝癌细胞衰老。
Hepatology. 2016 Apr;63(4):1213-26. doi: 10.1002/hep.28411. Epub 2016 Feb 19.
3
Hydroxylase Activity of ASPH Promotes Hepatocellular Carcinoma Metastasis Through Epithelial-to-Mesenchymal Transition Pathway.ASPH 的羟化酶活性通过上皮间质转化途径促进肝癌转移。
EBioMedicine. 2018 May;31:287-298. doi: 10.1016/j.ebiom.2018.05.004.
4
A cell-surface β-hydroxylase is a biomarker and therapeutic target for hepatocellular carcinoma.一种细胞表面β-羟化酶是肝细胞癌的生物标志物和治疗靶点。
Hepatology. 2014 Oct;60(4):1302-13. doi: 10.1002/hep.27275. Epub 2014 Aug 25.
5
Down-regulation of EGFL8 regulates migration, invasion and apoptosis of hepatocellular carcinoma through activating Notch signaling pathway.EGFL8 的下调通过激活 Notch 信号通路调节肝癌细胞的迁移、侵袭和凋亡。
BMC Cancer. 2021 Jun 15;21(1):704. doi: 10.1186/s12885-021-08327-0.
6
Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.天冬氨酸 β-羟化酶通过激活 SRC 信号通路促进胰腺导管腺癌转移。
J Hematol Oncol. 2019 Dec 30;12(1):144. doi: 10.1186/s13045-019-0837-z.
7
ASPH-notch Axis guided Exosomal delivery of Prometastatic Secretome renders breast Cancer multi-organ metastasis.ASPH-notch 轴指导外泌体递送促转移分泌组使乳腺癌多器官转移。
Mol Cancer. 2019 Nov 7;18(1):156. doi: 10.1186/s12943-019-1077-0.
8
LncRNA CSMD1-1 promotes the progression of Hepatocellular Carcinoma by activating MYC signaling.长链非编码 RNA CSMD1-1 通过激活 MYC 信号促进肝癌的进展。
Theranostics. 2020 Jun 12;10(17):7527-7544. doi: 10.7150/thno.45989. eCollection 2020.
9
IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.IGF2 通过表观遗传机制在肝细胞癌中上调,并且是实验模型中可操作的癌基因产物。
Gastroenterology. 2016 Dec;151(6):1192-1205. doi: 10.1053/j.gastro.2016.09.001. Epub 2016 Sep 7.
10
TRIM59 promotes tumor growth in hepatocellular carcinoma and regulates the cell cycle by degradation of protein phosphatase 1B.TRIM59 通过降解蛋白磷酸酶 1B 促进肝癌肿瘤生长并调控细胞周期。
Cancer Lett. 2020 Mar 31;473:13-24. doi: 10.1016/j.canlet.2019.12.030. Epub 2019 Dec 23.

引用本文的文献

1
HRASLS2 promotes the growth and glycolysis of pancreatic cancer by enhancing the stability of ASPH.HRASLS2通过增强ASPH的稳定性促进胰腺癌的生长和糖酵解。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Aug 20. doi: 10.1007/s00210-025-04522-z.
2
Current research of the Notch pathway in hepatocellular carcinoma.Notch信号通路在肝细胞癌中的当前研究
Eur J Med Res. 2025 May 20;30(1):402. doi: 10.1186/s40001-025-02626-z.
3
Exploring the genetic profiles linked to senescence in thyroid tumors: insights on predicting disease progression and immune responses.

本文引用的文献

1
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
2
Subcellular Distribution of p53 by the p53-Responsive lncRNA Determines Chemotherapeutic Response in Neuroblastoma.p53 反应性长非编码 RNA 决定神经母细胞瘤的化疗反应的亚细胞分布。
Cancer Res. 2021 Mar 15;81(6):1457-1471. doi: 10.1158/0008-5472.CAN-19-3499. Epub 2020 Dec 28.
3
PRL-3 facilitates Hepatocellular Carcinoma progression by co-amplifying with and activating FAK.
探索甲状腺肿瘤中与衰老相关的基因谱:对预测疾病进展和免疫反应的见解。
Front Oncol. 2025 Feb 6;15:1545656. doi: 10.3389/fonc.2025.1545656. eCollection 2025.
4
Heterogeneous Response of Tumor Cell Lines to Inhibition of Aspartate β-hydroxylase.肿瘤细胞系对天冬氨酸β-羟化酶抑制的异质性反应
J Cancer. 2024 Apr 29;15(11):3466-3480. doi: 10.7150/jca.94452. eCollection 2024.
5
SMYD4 monomethylates PRMT5 and forms a positive feedback loop to promote hepatocellular carcinoma progression.SMYD4 单甲基化 PRMT5 并形成正反馈回路以促进肝细胞癌进展。
Cancer Sci. 2024 May;115(5):1587-1601. doi: 10.1111/cas.16139. Epub 2024 Mar 4.
6
Exploration of prognosis and immunometabolism landscapes in ER+ breast cancer based on a novel lipid metabolism-related signature.基于新型脂代谢相关特征探讨 ER+ 乳腺癌的预后和免疫代谢图谱。
Front Immunol. 2023 Jul 4;14:1199465. doi: 10.3389/fimmu.2023.1199465. eCollection 2023.
PRL-3 通过与 FAK 共扩增和激活促进肝癌进展。
Theranostics. 2020 Aug 18;10(22):10345-10359. doi: 10.7150/thno.42069. eCollection 2020.
4
Aspartate β-hydroxylase as a target for cancer therapy.天冬氨酸β-羟化酶作为癌症治疗的靶点。
J Exp Clin Cancer Res. 2020 Aug 18;39(1):163. doi: 10.1186/s13046-020-01669-w.
5
Absence of Sac2/INPP5F enhances the phenotype of a Parkinson's disease mutation of synaptojanin 1.缺失 Sac2/INPP5F 增强突触融合蛋白 1 帕金森病突变体的表型。
Proc Natl Acad Sci U S A. 2020 Jun 2;117(22):12428-12434. doi: 10.1073/pnas.2004335117. Epub 2020 May 18.
6
ASPH-notch Axis guided Exosomal delivery of Prometastatic Secretome renders breast Cancer multi-organ metastasis.ASPH-notch 轴指导外泌体递送促转移分泌组使乳腺癌多器官转移。
Mol Cancer. 2019 Nov 7;18(1):156. doi: 10.1186/s12943-019-1077-0.
7
CD36 inhibits β-catenin/c-myc-mediated glycolysis through ubiquitination of GPC4 to repress colorectal tumorigenesis.CD36 通过泛素化 GPC4 抑制 β-catenin/c-myc 介导的糖酵解,从而抑制结直肠肿瘤发生。
Nat Commun. 2019 Sep 4;10(1):3981. doi: 10.1038/s41467-019-11662-3.
8
Prognostic value of inositol polyphosphate-5-phosphatase expression in recurrent and metastatic cutaneous squamous cell carcinoma.肌醇多聚磷酸-5-磷酸酶表达在复发性和转移性皮肤鳞状细胞癌中的预后价值。
J Am Acad Dermatol. 2020 Apr;82(4):846-853. doi: 10.1016/j.jaad.2019.08.027. Epub 2019 Aug 19.
9
Oral Selinexor-Dexamethasone for Triple-Class Refractory Multiple Myeloma.口服塞利尼索联合地塞米松治疗三药难治性多发性骨髓瘤。
N Engl J Med. 2019 Aug 22;381(8):727-738. doi: 10.1056/NEJMoa1903455.
10
Modelling liver cancer initiation with organoids derived from directly reprogrammed human hepatocytes.利用直接重编程的人源肝细胞衍生类器官建立肝癌起始模型。
Nat Cell Biol. 2019 Aug;21(8):1015-1026. doi: 10.1038/s41556-019-0359-5. Epub 2019 Jul 22.